Department of Medical Physics, San Raffaele Scientific Institute, Milano, Italy.
Department of Ophthalmology, San Raffaele Scientific Institute, Milano, Italy.
Br J Ophthalmol. 2018 Jun;102(6):833-839. doi: 10.1136/bjophthalmol-2017-310801. Epub 2017 Sep 13.
The aim of the present work is to assess the main predictors of the most clinically relevant radio-induced effects after Gamma Knife stereotactic radiosurgery (GKRS) for uveal melanoma (UM).
Medical records and three-dimensional dosimetry data of critical structures of 66 patients were retrospectively reviewed. Cox's proportional hazard model was used to identify clinical and dosimetric variables as independent risk factor for GKRS-related complications.
The fraction of the posterior segment receiving more than 20Gy (V20), Bruch's membrane rupture and tumour thickness were significant prognostic factors for neovascular glaucoma. A clear relationship with the dose received by 1% of the optic nerve (D1%) was found for radiation retinopathy and papillopathy. Multivariables models resulted for visual acuity (VA) reduction >20% of the basal value and for complete VA loss, both including largest tumour diameter and D1% to the optic nerve. The predictive model for complete VA loss includes also Bruch's membrane rupture. An alternative model for complete visual acuity loss, including the optic nerve-prescription isodose minimum distance, was also suggested.
We found clinical and dosimetric variables to clearly predict the risk of the main side effects after GKRS for UM. These results may provide dose constraints to critical structures, potentially able to reduce side effects. Constraining D1% to the optic nerve below 12-13Gy may result in a dramatic reduction of blindness risk, while reducing V20 of the posterior segment of the bulb could limit the neovascular glaucoma onset.
本研究旨在评估伽玛刀立体定向放射外科(GKRS)治疗葡萄膜黑色素瘤(UM)后最具临床相关性的放射性副作用的主要预测因素。
回顾性分析了 66 例患者的病历和关键结构的三维剂量学数据。Cox 比例风险模型用于确定临床和剂量学变量是否为 GKRS 相关并发症的独立危险因素。
后部组织接受超过 20Gy(V20)的部分、Bruch 膜破裂和肿瘤厚度是新生血管性青光眼的显著预后因素。视神经接受 1%剂量(D1%)与放射性视网膜病变和视乳头病变明显相关。视力下降超过基础值 20%和完全视力丧失的多变量模型均包括最大肿瘤直径和视神经 D1%。完全视力丧失的预测模型还包括 Bruch 膜破裂。还提出了一种包括视神经处方等剂量线最小距离的完全视力丧失替代模型。
我们发现临床和剂量学变量可明确预测 GKRS 治疗 UM 后主要副作用的风险。这些结果可为关键结构提供剂量限制,可能降低副作用风险。将视神经 D1%限制在 12-13Gy 以下可能会显著降低失明风险,而降低眼球后部 V20 可限制新生血管性青光眼的发生。